← Back to Search

Educational Video for Vaccine Hesitancy in Sickle Cell Disease

N/A

Recruiting

Led By John Strouse, MD, PhD

Research Sponsored by Duke University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Diagnosis of sickle cell disease

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up before and after watching video

Awards & highlights

Study Summary

This trial tests a COVID-19 info video to reduce vaccine hesitancy in adults w/ sickle cell. Participants watch a video & answer surveys before & after to measure impact.

Who is the study for?

This trial is for adults with sickle cell disease who are hesitant about getting the COVID-19 vaccine. They must be able to read and understand English as they will need to complete a survey.Check my eligibility

What is being tested?

The study tests whether a specially made video with COVID-19 vaccination information can help reduce vaccine hesitancy in adults with sickle cell disease. Participants watch the video and then answer survey questions.See study design

What are the potential side effects?

Since this trial involves watching an informational video rather than taking medication, there are no direct medical side effects associated with participating in this study.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with sickle cell disease.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ before and after watching video

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~before and after watching video

This trial's timeline: 3 weeks for screening, Varies for treatment, and before and after watching video for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Vaccine hesitancy

Trial Design

1Treatment groups

Experimental Treatment

Group I: Adults With Sickle Cell DiseaseExperimental Treatment1 Intervention

Age 18 years or older

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Duke UniversityLead Sponsor

2,358 Previous Clinical Trials

3,419,819 Total Patients Enrolled

American Society of HematologyOTHER

11 Previous Clinical Trials

20,608 Total Patients Enrolled

John Strouse, MD, PhDPrincipal InvestigatorDuke University

Media Library

Adults With Sickle Cell Disease Clinical Trial Eligibility Overview. Trial Name: NCT05998824 — N/A

Sickle Cell Disease Research Study Groups: Adults With Sickle Cell Disease

Sickle Cell Disease Clinical Trial 2023: Adults With Sickle Cell Disease Highlights & Side Effects. Trial Name: NCT05998824 — N/A

Adults With Sickle Cell Disease 2023 Treatment Timeline for Medical Study. Trial Name: NCT05998824 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this trial's protocol permit those over eighty-five years to participate?

"Prospective participants must be between 18 years of age and a century old to qualify for inclusion in this research."

Answered by AI

Is enrollment for this experiment still open?

"Information provided on clinicaltrials.gov reveals that this trial has ceased recruitment for the time being, having first been listed on August 23rd 2023 and last updated on August 17th 2023. Despite not actively searching for new patients at present, 911 other medical studies are still recruiting from volunteers."

Answered by AI

Do I fulfill the criteria necessary for enrollment in this research project?

"To qualify for this medical trial, prospective participants must have a diagnosis of sickle cell and be between 18-100 years old. At present the maximum enrollment is 250 individuals."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

COVID-19 Vaccination Hesitancy in Adults With Sickle Cell Disease

John J. Strouse, M.D., Ph.D. 2023. "COVID-19 Vaccination Hesitancy in Adults With Sickle Cell Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05998824.